About
Manifold Bio develops a high throughput in vivo platform that tests hundreds of biologics simultaneously in a single animal to generate large-scale data sets enabling AI-driven development of tissue-targeting medicines, starting with neuroshuttles.
Explore Manifold Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.